Scout Bio

OverviewSuggest Edit

Scout Bio is a biotechnology company focused on innovating pet medicine by delivering a pipeline of one-time therapeutics for major chronic pet health conditions. The Company is advancing a number of programs across chronic kidney disease, chronic pain, and the inflammatory skin condition atopic dermatitis. Scout Bio's approach is to deliver a long-term expression of therapeutic proteins in pet patients using adeno-associated viral (AAV) vector technology, administered through a single intramuscular injection.

TypePrivate
Founded2016
HQPhiladelphia, PA, US
Websitescoutbio.co

Latest Updates

Employees (est.) (Apr 2019)4
Cybersecurity ratingAMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Scout Bio

Mark Heffernan

Mark Heffernan

Chief Executive Officer
Matt Wilson

Matt Wilson

VP, Product Discovery & External Innovation
Samantha Busfield

Samantha Busfield

VP, Preclinical Development
Damian Lismore

Damian Lismore

Chief Financial Officer
Jodi Hayes

Jodi Hayes

VP, Program Management
Patrick Heron

Patrick Heron

Director
Show more

Scout Bio Office Locations

Scout Bio has an office in Philadelphia
Philadelphia, PA, US (HQ)
100 N 18th St #300
Show all (1)

Scout Bio Financials and Metrics

Summary Metrics

Founding Date

2016

Scout Bio total Funding

$29.3 m

Scout Bio latest funding size

$20 m

Time since last funding

3 years ago

Scout Bio investors

Scout Bio's latest funding round in April 2019 was reported to be $20 m. In total, Scout Bio has raised $29.3 m
Show all financial metrics

Scout Bio Cybersecurity Score

Cybersecurity ratingPremium dataset

A

95/100

SecurityScorecard logo

Scout Bio Online and Social Media Presence

Embed Graph

Scout Bio News and Updates

Scout Bio Named Best New Start-Up for 2021

IHS Markit recognizes Scout Bio for pioneering therapies in companion animal medicine IHS Markit recognizes Scout Bio for pioneering therapies in companion animal medicine

Scout Bio Initiates Multi-Center Clinical Study of Gene Therapy for Chronic Arthritis Pain In Cats

- First vectorized antibody gene therapy to be studied in pets- Strong initial in-species data support therapeutic profile of one-time gene therapy designed for long-term pain management- Novel monthly pain management antibody therapy also assessed as part of study design- Topline data expected in Q…

Scout Bio Closes $33 Million Series B2 Financing to Advance its Portfolio of Single Injection Gene Therapy Technology for the Treatment of Chronic Diseases in Pets

- Proceeds to support advancing single injection Adeno-Associated Viral (AAV) vector therapeutics targeting chronic companion animal diseases including diabetes, pain, and anemia associated with chronic kidney disease (CKD)

Scout Bio to Present at Upcoming October Investor Conferences

PHILADELPHIA, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Scout Bio, a biotechnology company focused on revolutionizing pet medicine by delivering a pipeline of one-time AAV gene therapies for major chronic pet health conditions, today announced that Mark Heffernan, Chief Executive Officer, will present at …

Scout Bio Successfully Completes Pilot Clinical Study of SB-001, a Single-Injection AAV Gene Therapy for the Treatment of Feline CKD-Associated Anemia

PHILADELPHIA, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Scout Bio today announced the successful completion of a CKD-associated anemia study in client owned cats treated with SB-001, an AAV expressing feline erythropoietin (fEPO). The study demonstrated a prolonged therapeutic effect with statistically s…

Scout Bio to Present at Wells Fargo 2021 Virtual Healthcare Conference

PHILADELPHIA, Sept. 02, 2021 (GLOBE NEWSWIRE) -- Scout Bio today announced that Mark Heffernan, Chief Executive Officer, will present at the upcoming Wells Fargo Virtual Healthcare Conference on Thursday, September 9, 2021 at 4:00 p.m. ET.
Show more

Scout Bio Blogs

Scout Bio Initiates Multi-Center Clinical Study of Gene Therapy for Chronic Arthritis Pain In Cats

– First vectorized antibody gene therapy to be studied in pets – Strong initial in-species data support therapeutic profile of one-time gene therapy designed for long-term pain management –… The post Scout Bio Initiates Multi-Center Clinical Study of Gene Therapy for Chronic Arthritis Pain In Cats …

Scout Bio Closes $33 Million Series B2 Financing to Advance its Portfolio of Single Injection Gene Therapy Technology for the Treatment of Chronic Diseases in Pets

– Proceeds to support advancing single injection Adeno-Associated Viral (AAV) vector therapeutics targeting chronic companion animal diseases including diabetes, pain, and anemia associated with chronic kidney disease (CKD) – New… The post Scout Bio Closes $33 Million Series B2 Financing to Advance…

Scout Bio Successfully Completes Pilot Clinical Study of SB-001, A Single-Injection AAV Gene Therapy for the Treatment of Feline CKD-Associated Anemia

PHILADELPHIA, September 9, 2021 — Scout Bio today announced the successful completion of a CKD-associated anemia study in client owned cats treated with SB-001, an AAV expressing feline erythropoietin (fEPO).… The post Scout Bio Successfully Completes Pilot Clinical Study of SB-001, A Single-Injecti…

No current openings. Please check back soon!

To fill out a general application, click below The post No current openings. Please check back soon! appeared first on Scout Bio.

Scout Bio Appoints Clinical Research Leader Dr. Anne Traas as Chief Development Officer

PHILADELPHIA, October 28, 2019 – Scout Bio, a biotechnology company focused on revolutionizing pet medicine by delivering a pipeline of one-time therapeutics for major chronic pet health conditions, today… The post Scout Bio Appoints Clinical Research Leader Dr. Anne Traas as Chief Development Offic…

Discovery Research Scientist

Philadelphia, PA Full-time ABOUT US At Scout Bio (www.scoutbio.co) our mission is to create innovative medicines for companion animals that are more convenient, effective and safe than those currently… The post Discovery Research Scientist appeared first on Scout Bio.

Scout Bio Frequently Asked Questions

  • When was Scout Bio founded?

    Scout Bio was founded in 2016.

  • Who are Scout Bio key executives?

    Scout Bio's key executives are Mark Heffernan, Matt Wilson and Samantha Busfield.

  • How many employees does Scout Bio have?

    Scout Bio has 4 employees.

  • Who are Scout Bio competitors?

    Competitors of Scout Bio include Invetx, Merck Animal Health USA and Bioceltix.

  • Where is Scout Bio headquarters?

    Scout Bio headquarters is located at 100 N 18th St #300, Philadelphia.

  • Where are Scout Bio offices?

    Scout Bio has an office in Philadelphia.

  • How many offices does Scout Bio have?

    Scout Bio has 1 office.